| SCHEDULE OF RECONCILIATION OF BASIC AND DILUTED COMMON SHARES OUTSTANDING |
The
following tables provide a reconciliation of the data used in the calculation of basic and diluted ordinary shares outstanding for the
three-month period ended June 30, 2026, the three-month period ended June 30, 2025, the six-month period ended June 30, 2026, and the
six-month period ended June 30, 2025, respectively.
SCHEDULE OF RECONCILIATION OF BASIC AND DILUTED COMMON SHARES OUTSTANDING
| Date | |
Transaction
Detail | |
Change
in Shares | | |
Three-month period
ended June
30, 2026, Weighted
Average
Ordinary Shares
Outstanding | |
| April
1, 2026 | |
Beginning
Balance | |
| | | |
| 100,847,255 | |
| April,
10, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 3,000 | | |
| 2,671 | |
| May
20, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 1,499 | | |
| 675 | |
| June
30, 2026 | |
Ending
Balance | |
| | | |
| 100,850,601 | |
| Date | |
Transaction
Detail | |
Change
in Shares | | |
Three-month period
ended June
30, 2025, Weighted
Average
Ordinary Shares
Outstanding | |
| April
1, 2025 | |
Beginning
Balance | |
| | | |
| 96,352,966 | |
| April
22, 2025 | |
Settlement
of liability-classified share-based compensation | |
| 100,001 | | |
| 75,825 | |
| June
30, 2025 | |
Ending
Balance | |
| | | |
| 96,428,791 | |
| Date | |
Transaction
Detail | |
Change
in Shares | | |
Six-month
period
ended
June
30, 2026,
Weighted
Average
Ordinary
Shares
Outstanding | |
| January
1, 2026 | |
Beginning
Balance | |
| | | |
| 100,787,173 | |
| January
15, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 833 | | |
| 764 | |
| January
30, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 7,332 | | |
| 6,116 | |
| February
25, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 1,666 | | |
| 1,151 | |
| March
13, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 250 | | |
| 30,110 | |
| March
13, 2026 | |
Settlement
of liability-classified share-based compensation | |
| 50,001 | | |
| 151 | |
| April,
10, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 3,000 | | |
| 1,343 | |
| May
20, 2026 | |
Equity-classified
Restricted Stock Issuance | |
| 1,499 | | |
| 340 | |
| June
30, 2026 | |
Ending
Balance | |
| | | |
| 100,827,148 | |
| Date | |
Transaction
Detail | |
Change
in Shares | | |
Six-month period
ended June
30, 2025, Weighted
Average
Ordinary Shares
Outstanding | |
| January
1, 2025 | |
Beginning
Balance | |
| | | |
| 96,045,856 | |
| January
6, 2025 | |
Settlement
of liability-classified share-based compensation | |
| 61,353 | | |
| 59,319 | |
| February
17, 2025 | |
Equity-classified
Restricted Stock Issuance | |
| 666 | | |
| 489 | |
| February
27, 2025 | |
Equity-classified
Restricted Stock Issuance | |
| 1,000 | | |
| 680 | |
| March
17, 2025 | |
Equity-classified
Restricted Stock Issuance | |
| 12,430 | | |
| 7,211 | |
| March
18, 2025 | |
Equity-classified
Restricted Stock Issuance | |
| 231,661 | | |
| 133,109 | |
| April
22, 2025 | |
Settlement
of liability-classified share-based compensation | |
| 100,001 | | |
| 38,122 | |
| June
30, 2025 | |
Ending
Balance | |
| | | |
| 96,284,786 | |
|
| SCHEDULE OF BASIC AND DILUTED EARNINGS PER COMMON SHARE |
The
following tables provide the computation of basic and diluted earnings per share (“EPS”) for the three-month period
ended June 30, 2026, the three-month period ended June 30, 2025, the six-month period ended June 30, 2026, and the six-month period
ended June 30, 2025, respectively (in US$ thousands, except share data and per share amounts):
SCHEDULE OF BASIC AND DILUTED EARNINGS PER COMMON SHARE
| | |
For
the three-month period ended | |
| | |
June
30, 2026 | | |
June
30, 2025 | |
| | |
Net
income to Ordinary Shareholders | | |
Weighted-average
ordinary shares outstanding | | |
EPS | | |
Net
income to Ordinary Shareholders | | |
Weighted-average
ordinary shares outstanding | | |
EPS | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Basic
EPS - ordinary shares | |
$ | 44,017 | | |
| 100,850,601 | | |
$ | 0.44 | | |
$ | 15,201 | | |
| 96,428,791 | | |
$ | 0.16 | |
| Restricted
stock units | |
| - | | |
| 2,367,809 | | |
| - | | |
| - | | |
| - | | |
| - | |
| Antidilution
sequencing - subtotal | |
| 44,017 | | |
| 103,218,410 | | |
| 0.43 | | |
| 15,201 | | |
| 96,428,791 | | |
| 0.16 | |
| 35,540,380
warrants @ $5.75 per half share | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| May
30, 2025, tender offer to exchange 35,540,380 warrants at a maximum of 0.10 ordinary shares per warrant | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,210,716 | | |
| - | |
| Diluted
EPS - ordinary shares | |
$ | 44,017 | | |
| 103,218,410 | | |
$ | 0.43 | | |
$ | 15,201 | | |
| 97,639,507 | | |
$ | 0.16 | |
| | |
For
the six-month period ended | |
| | |
June
30, 2026 | | |
June
30, 2025 | |
| | |
Net
income to Ordinary Shareholders | | |
Weighted-average
ordinary shares outstanding | | |
EPS | | |
Net
income to Ordinary Shareholders | | |
Weighted-average
ordinary shares outstanding | | |
EPS | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Basic
EPS - ordinary shares | |
$ | 67,844 | | |
| 100,827,148 | | |
$ | 0.67 | | |
$ | 25,592 | | |
| 96,284,786 | | |
$ | 0.27 | |
| Restricted
stock units | |
| - | | |
| 2,257,430 | | |
| - | | |
| - | | |
| 258,726 | | |
| - | |
| Antidilution
sequencing - subtotal | |
| 67,844 | | |
| 103,084,578 | | |
| 0.66 | | |
| 25,592 | | |
| 96,543,512 | | |
| 0.27 | |
| 35,540,380
warrants @ $5.75 per half share | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| May
30, 2025, tender offer to exchange 35,540,380 warrants at a maximum of 0.10 ordinary shares per warrant | |
| - | | |
| - | | |
| - | | |
| - | | |
| 608,703 | | |
| - | |
| Diluted
EPS - ordinary shares | |
$ | 67,844 | | |
| 103,084,578 | | |
$ | 0.66 | | |
$ | 25,592 | | |
| 97,152,215 | | |
$ | 0.26 | |
|